The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.15
Bid: 98.35
Ask: 98.50
Change: 0.40 (0.41%)
Spread: 0.15 (0.153%)
Open: 98.60
High: 99.30
Low: 97.90
Prev. Close: 97.75
SRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

11 Jul 2023 12:00

RNS Number : 6660F
Sirius Real Estate Limited
11 July 2023
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

LEI: 213800NURUF5W8QSK566

ISIN Code: GG00B1W3VF54

 

11 July 2023

Sirius Real Estate Limited

("Sirius Real Estate", "Sirius" or the "Company")

 

Result of Annual General Meeting

Sirius Real Estate announces that at the Annual General Meeting (the "Meeting") held yesterday, Monday, 10 July 2023, all resolutions were duly passed.

The result of the vote on each resolution is shown below:

Resolution proposed at the Meeting

Votes for resolution as a percentage of total number of shares voted at the Meeting

Votes against resolution as a percentage of total number of shares voted at the Meeting

Number of shares voted at the Meeting

Number of shares voted at the Meeting as a percentage of shares in issue*

Number of shares abstained/

withheld as a percentage of shares in issue*

Ordinary Resolutions

 

1: To receive and approve Annual Report 2023.

100.00%

0.00%

837,649,490

71.12%

0.30%

2: To elect Chris Bowman as a Director.

99.60%

0.40%

838,267,531

71.18%

0.24%

3: To re-elect Caroline Britton as a Director.

98.20%

1.80%

838,267,531

71.18%

0.24%

4: To re-elect Mark Cherry as a Director.

97.22%

2.78%

838,267,531

71.18%

0.24%

5: To re-elect Kelly Cleveland as a Director.

97.22%

2.78%

838,267,531

71.18%

0.24%

6: To re-elect Andrew Coombs as a Director.

98.97%

1.03%

838,267,531

71.18%

0.24%

7: To re-elect Joanne Kenrick as a Director.

96.91%

3.09%

838,267,531

71.18%

0.24%

8: To re-elect Daniel Kitchen as a Director.

94.96%

5.04%

838,267,531

71.18%

0.24%

9: To re-elect James Peggie as a Director.

97.70%

2.30%

838,267,530

71.18%

0.24%

10: To re-appoint Ernst & Young LLP as auditors.

99.91%

0.09%

838,252,389

71.18%

0.25%

11: To approve fixing the auditors' remuneration.

99.91%

0.09%

838,266,031

71.18%

0.24%

12: (non-binding): To approve the dividend.

100.00%

0.00%

838,267,531

71.18%

0.24%

13. (non-binding): To approve the Remuneration Policy.

91.72%

8.28%

838,169,985

71.17%

0.25%

14. (non-binding): To approve the Implementation Report on the Remuneration Policy.

87.65%

12.35%

837,344,885

71.10%

0.32%

15: To approve scrip dividend scheme for financial year ending 31 March 2024.

99.64%

0.36%

838,166,559

71.17%

0.25%

16: To authorise the Directors generally and unconditionally to allot equity securities.

77.50%

22.50%

838,166,559

71.17%

0.25%

Special Resolutions

 

17: To authorise the Directors to issue of up to ten percent. (10%) of issued share capital as if pre-emption rights did not apply.

82.56%

17.44%

838,261,110

71.18%

0.24%

18: To authorise the Directors to issue of an additional ten percent. (10%) of issued share capital as if pre-emption rights did not apply for acquisitions/capital investments.

83.79%

16.21%

838,261,110

71.18%

0.24%

19: To authorise the Company or any of its subsidiaries to make market purchases of ordinary Shares of the Company.

99.50%

0.50%

836,669,786

71.04%

0.38%

 

Note:

\* The total number of shares in issue as at the date of the Meeting was 1,177,722,985, of which zero were treasury shares.

 

In accordance with provision 4 of Section 1 of the UK Corporate Governance Code 2018(the "UK Code"), the Company notes the votes cast against Resolution 16 were greater than 20% of those exercised in total by the Company's shareholders.

 

The Board has been engaging with shareholders in respect of Resolution 16 in the lead up to the Meeting and has a good understanding of the concerns of some of Sirius' major shareholders. It is, however, the intention to extend the consultation process and report to shareholders in line with the requirements of the UK Code.

 

The Company extends an invitation to shareholders to engage with the Company. Should shareholders wish to contact the Company with any concerns, they are requested to send their concerns in writing to the Company Secretary at cosec@sirius-real-estate.com, by not later than close of business on Monday, 31 July 2023. Sirius will address those concerns in its consultation process identified above.

 

In accordance with Listing Rule 9.6.2 of the Financial Conduct Authority's Listing Rules, copies of the resolutions passed as special business will be submitted to the National Storage Mechanism and will shortly be available for inspection.

 

The full text of the resolutions can be found in the 'Investors' section of the Company website, under 'Results & presentations & notices', and is available for inspection here https://www.sirius-real-estate.com/investors/results-presentations-notices/.

For further information:

Sirius Real Estate

Andrew Coombs, CEO

Alistair Marks, CIO and interim CFO

+49 (0) 30 285 010 110

 

FTI Consulting (Financial PR)

Richard Sunderland

James McEwan

Talia Shirion

 

SiriusRealEstate@fticonsulting.com 

+44 (0) 20 3727 1000

 

 

JSE Sponsor

PSG Capital

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUAARROBUBAAR
Date   Source Headline
27th Mar 20237:00 amRNSAppointment of new Chief Financial Officer
22nd Mar 20237:00 amRNSNotice of Trading Update
13th Feb 20237:00 amRNSChange of Registered Office Address
27th Jan 20237:00 amRNSDirector/PDMR Shareholding
18th Jan 20231:00 pmRNSDirector/PDMR Shareholding
15th Dec 202212:34 pmEQSProactive research analyst on Sirius Real Estate
30th Nov 20222:00 pmRNSTotal Voting Rights
23rd Nov 20222:00 pmRNSAllotment of 2018 Long Term Incentive Plan Shares
21st Nov 20222:33 pmEQSSirius Real Estate dividend tracks FFO higher
21st Nov 20227:00 amRNSHalf-year Report
17th Nov 20227:00 amRNSTrading Statement
7th Nov 20222:30 pmRNSFITCH REAFFIRMS SIRIUS’ BBB INVESTMENT RATING
27th Oct 202210:00 amRNSHolding(s) in Company
24th Oct 202212:00 pmRNSHolding(s) in Company
10th Oct 20227:01 amRNSSouth Africa Roadshow
10th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSEARLY REFINANCING OF NEXT MAJOR DEBT EXPIRY
4th Oct 202212:00 pmRNSHolding(s) in Company
4th Oct 202211:43 amRNSACQUISITIONS AND DISPOSALS UPDATE
30th Sep 20222:00 pmRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSNotice of Trading Update
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20223:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20222:00 pmRNSDirector/PDMR Shareholding
20th Sep 202212:00 pmRNSHolding(s) in Company
15th Sep 202210:00 amRNSDirector/PDMR Shareholding
8th Sep 20224:00 pmRNSDealing in Securities
8th Sep 202210:00 amRNSHolding(s) in Company
5th Sep 20224:00 pmRNSDirector/PDMR Shareholding
31st Aug 20222:00 pmRNSTotal Voting Rights
25th Aug 20222:00 pmRNSDirector/PDMR Shareholding
18th Aug 20222:00 pmRNSDirector/PDMR Shareholding
18th Aug 20229:00 amRNSAdmission of Scrip Shares
16th Aug 20228:30 amRNSCHANGE OF CHIEF FINANCIAL OFFICER (“CFO”)
10th Aug 20222:00 pmRNSDividend & Allotment of Scrip Dividend
3rd Aug 20224:15 pmRNSDirector/PDMR Shareholding
29th Jul 20223:00 pmRNSTotal Voting Rights
21st Jul 20223:00 pmRNSDirector/PDMR Shareholding
19th Jul 20223:00 pmRNSDirector/PDMR Shareholding
18th Jul 20223:00 pmRNSAllotment of 2018 Long Term Incentive Plan Shares
12th Jul 20223:00 pmRNSDirector/PDMR Shareholding
12th Jul 202211:00 amRNSDirector/PDMR Shareholding
11th Jul 202211:00 amRNSHolding(s) in Company
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:00 amRNSDealing in Securities
7th Jul 20224:00 pmRNSDirector/PDMR Shareholding
7th Jul 202210:00 amRNSCash fraction applicable to the Scrip Dividend
7th Jul 20227:00 amRNSSIRIUS COMPLETES £16M SALE OF BIZSPACE CAMBERWELL
6th Jul 20224:00 pmRNSResult of AGM
6th Jul 20227:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.